finance.yahoo.com
Bioasis Announces Director Resignation
BIOASIS TECHNOLOGIES INC. , , a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the delivery of therapeutics across the blood-brain barrier and the treatment of central nervous system disorders in areas of high unmet medical need, including